µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© 9ucoQ@
98zJ?NaD&
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© M6]:^;p'
1¡¢Co-stimulators (or co-stimulating molecules) /k\)q
2¡¢NK-kB ~^ ' + .
3¡¢Immunoglobulin superfamily +]H!q
W:
4¡¢antigen-presenting cell (APC) hG9Mp!d91
5¡¢death domain $Zrc-tkV
6¡¢CCR and CXCR 5HAAa I
7¡¢Lectin (or mitogen) PP_ar{|7
8¡¢Clusters of differentiation, CD) *'n=L
B8R
9¡¢B7 family Fb{HiU9<!
10¡¢Cytotoxic T lymphocyte, CTL) FPE6H:'
11¡¢IL-15 and IL-15 receptor (IL-15R) vhU
$GG8
12¡¢MHC restriction q?0
&0
13¡¢Affinity-chromatography xWWVU}fd1
14¡¢Cyctosprin A, CsA 7$L*nf
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) weOga\
u@4khN:
^p
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© /5f=a
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 (gutDUO;
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ _tnoq;X[
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ |5BvVqn
T<0V ^B7
Èý¡¢ÎÊ´ðÌ⣨25·Ö£© lp1GK/!s
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ Ige*tOv2
ѪҺ²¡Ñ§×¨Òµ£º X&%;(`
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿